Emiko Higashi

Ms. Higashi has served as a director since May 2017. Ms. Higashi currently serves as the chair of our Corporate Governance/Nominating Committee and member of our Audit Committee and Corporate Development Committee. Ms. Higashi also serves on the boards of Takeda Pharmaceutical Company Ltd. (TSE/NYSE), where she serves as the chair of the Compensation Committee and member of the Nomination Committee, and has served on the Audit Supervisory Committee; Rapidus Corporation, a Japanese semiconductor foundry business focused on 2 nm and beyond manufacturing. Ms. Higashi is a member of the Industrial Structure Council, appointed in July 2025 by METI, Japan. She served on the boards of KLA Corporation (Nasdaq) until November 2025, One Equity Partners Open Water I Corp (Nasdaq) until December 2022, Sanken Electric (TSE) until June 2021, MetLife Insurance KK until September 2019, and InvenSense, Inc. (NYSE) until May 2017. Ms. Higashi is a founder of Tohmon Capital Partners, LLC (formerly Tomon Partners, LLC.) Prior to Tohmon Capital Partners, she was a co-founder and Chief Executive Officer of Gilo Ventures, a technology- focused venture capital firm based in Silicon Valley and Tel Aviv, from 2000 to 2002. Before that, Ms. Higashi spent 15 years in investment banking. Beginning her investment banking career at Lehman Brothers from 1985 to 1988, Ms. Higashi was a founding member of Wasserstein Perella & Co. and the head of that firm’s technology M&A business from 1988 to 1994 and subsequently served as a managing director in charge of